On the surface, CVS Caremark and Walgreen seem pretty similar. But dig deeper, and you see some big differences: CVS has a huge pharmacy benefit management (PBM) segment and has played more aggressively in retail clinics, while Walgreen's agreement with Alliance Boots (and potential buyout of the company next year) provides it with intriguing overseas growth opportunities.
In the video below, from Where The Money Is, the Motley Fool's investment show, health care analysts Michael Douglass and David Williamson consider the best stock.
Leaked: The coming multi-bagger tsunami?
The best investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There is a product in development that will revolutionize not how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns you will need The Motley Fool's new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.
The article Can CVS Trounce Walgreen? originally appeared on Fool.com.David Williamson has no position in any stocks mentioned. Michael Douglass has no position in any stocks mentioned. The Motley Fool recommends CVS Caremark. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2014 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.